BioVersys AG
Quick facts
Phase 3 pipeline
- Best Available Therapy (BAT)
BAT is a best available therapy comparator arm used in clinical trials, not a drug with its own mechanism of action.
Phase 2 pipeline
- BV100 plus Polymyxin B · Infectious Disease
BV100 targets the bacterial cell membrane, disrupting its integrity and leading to cell death, in combination with Polymyxin B, an antibiotic that targets the bacterial cell wall. - HRZE plus Alpe375
- HRZE plus AlpE500
- HRZE plus AlpE625
Phase 1 pipeline
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: